On April 18, 2025, Imexpharm announced Q1 business results, reporting net revenue of VND 594 billion and profit before tax of VND 95 billion, up 21% and 23%...
Most businesses that are in need of capital in the current economic scenario expect a regulatory adjustment, as most of them are facing extreme difficulties in running...
If the ECB fails to prevent destabilising fragmentation risk in the bond market with its soon-to-be revealed plan it could hamper the euro’s chances of recovery.
Financial markets did not seem too flustered amid the Russia-Ukraine crisis, even though it came as a surprise to most.
VN
EN